Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

2231 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

2231 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Phase II Oncology
Pan Tumor Rollover Study
Pan Tumor Rollover Study is Recruiting • Phase II • Oncology • NCT03899155. Main Objective of this study is to examine long-term safety of…
01 Apr 2026 NCT03899155
active not recruiting Phase III
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids is Active…
31 Mar 2026 NCT05653219
active not recruiting Respiratory / COPD / Asthma
Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema
Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema is Active Not Recruiting • Phase not applicable •…
31 Mar 2026 NCT05949645
active not recruiting Phase III
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) is Active Not Recruiting •…
31 Mar 2026 NCT04162210
● Recruiting Phase III Rare Diseases
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants…
31 Mar 2026 NCT07007065
active not recruiting Phase II / Phase III Oncology
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC is Active Not Recruiting • Phase2, Phase3 • Oncology • NCT06295731. Review the linked…
31 Mar 2026 NCT06295731
● Recruiting Phase II / Phase III Infectious Disease
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) is Recruiting • Phase2, Phase3 • Infectious Disease • NCT05416307. Review the linked…
31 Mar 2026 NCT05416307
● Recruiting Phase I Oncology
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) is Recruiting • Phase I…
31 Mar 2026 NCT04929223
● Recruiting Oncology
WATER IV Prostate Cancer
WATER IV Prostate Cancer is Recruiting • Phase not applicable • Oncology • NCT06651632. This is a multicenter, prospective, randomized clinical trial that aims…
31 Mar 2026 NCT06651632
● Recruiting Phase III Oncology
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced…
31 Mar 2026 NCT06452277
● Recruiting Phase III Oncology
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated…
31 Mar 2026 NCT05894239
● Recruiting Phase III Oncology
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator’s Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator’s Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1…
31 Mar 2026 NCT06103864
● Recruiting Phase I Neurology
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD is Recruiting • Phase I • Neurology • NCT05231785. The…
31 Mar 2026 NCT05231785
● Recruiting Phase III Neurology
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer’s Disease (MINDSET 2)
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer’s Disease (MINDSET 2) is Recruiting • Phase…
31 Mar 2026 NCT06976203
● Recruiting Phase I Neurology
A Study to Evaluate ALN-5288 in Patients With Alzheimer’s Disease
A Study to Evaluate ALN-5288 in Patients With Alzheimer’s Disease is Recruiting • Phase I • Neurology • NCT07214727. The purpose of this study…
31 Mar 2026 NCT07214727
● Recruiting
LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)
LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM) is Recruiting • Phase not applicable • NCT06446739. An estimated…
31 Mar 2026 NCT06446739
● Recruiting Phase III Diabetes / Metabolic
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD) is Recruiting • Phase III • Diabetes / Metabolic…
31 Mar 2026 NCT04939935
● Recruiting Phase I Oncology
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal…
31 Mar 2026 NCT07293351
● Recruiting Phase III Infectious Disease
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide is Recruiting • Phase III • Infectious Disease…
31 Mar 2026 NCT07128550
● Recruiting Phase III Rheumatology
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn’s Disease
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn’s Disease is Recruiting • Phase III • Rheumatology • NCT05923073. The…
31 Mar 2026 NCT05923073
● Recruiting Phase III Respiratory / COPD / Asthma
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) is Recruiting • Phase III • Respiratory /…
31 Mar 2026 NCT05943535
● Recruiting Phase III Oncology
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) is Recruiting…
31 Mar 2026 NCT06692738
● Recruiting Phase III Oncology
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007) is Recruiting • Phase III • Oncology…
31 Mar 2026 NCT07190248
● Recruiting Phase III Oncology
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer…
31 Mar 2026 NCT06561386
● Recruiting Phase II Respiratory / COPD / Asthma
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma) is Recruiting • Phase II • Respiratory / COPD / Asthma • NCT06940141.…
31 Mar 2026 NCT06940141
● Recruiting Phase II Respiratory / COPD / Asthma
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD) is Recruiting • Phase II • Respiratory / COPD / Asthma • NCT06940154.…
31 Mar 2026 NCT06940154
● Recruiting Respiratory / COPD / Asthma
Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis
Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis is Recruiting • Phase not applicable • Respiratory /…
31 Mar 2026 NCT07502677
● Recruiting Cardiology / Cardiovascular
Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation
Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation is Recruiting • Phase not applicable • Cardiology…
31 Mar 2026 NCT07073781
● Recruiting Phase II Cardiology / Cardiovascular
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy is Recruiting • Phase II • Cardiology / Cardiovascular • NCT06393712. The…
31 Mar 2026 NCT06393712
● Recruiting Phase III Cardiology / Cardiovascular
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy is Recruiting • Phase III • Cardiology / Cardiovascular • NCT07052903.…
31 Mar 2026 NCT07052903
● Recruiting Phase II Cardiology / Cardiovascular
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis is Recruiting • Phase II • Cardiology / Cardiovascular • NCT07010159. This study is being done…
31 Mar 2026 NCT07010159
● Recruiting Cardiology / Cardiovascular
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT05701917. This…
31 Mar 2026 NCT05701917
● Recruiting Phase III Cardiology / Cardiovascular
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease is Recruiting • Phase…
31 Mar 2026 NCT07181109
● Recruiting Phase III Oncology
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator’s Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator’s Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients is Recruiting…
31 Mar 2026 NCT06496178
● Recruiting Phase II Oncology
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations is Recruiting • Phase II • Oncology •…
31 Mar 2026 NCT06581432
● Recruiting Phase I Oncology
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) is Recruiting • Phase I • Oncology • NCT06217822.…
31 Mar 2026 NCT06217822
● Recruiting Phase II Oncology
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy is Recruiting • Phase…
31 Mar 2026 NCT07106762
● Recruiting Phase III Oncology
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer is Recruiting • Phase III…
31 Mar 2026 NCT06340568
● Recruiting Oncology
Targeted Pediatric High-Grade Glioma Therapy
Targeted Pediatric High-Grade Glioma Therapy is Recruiting • Phase not applicable • Oncology • NCT05839379. The goal of this study is to perform genetic…
31 Mar 2026 NCT05839379
● Recruiting Phase I Oncology
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion…
31 Mar 2026 NCT06360354
active not recruiting Phase II
Iptacopan in Patients With ANCA Associated Vasculitis
Iptacopan in Patients With ANCA Associated Vasculitis is Active Not Recruiting • Phase II • NCT06388941. Review the linked registry entry for study design,…
30 Mar 2026 NCT06388941
● Recruiting Diabetes / Metabolic
The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.
The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. is Recruiting • Phase not…
30 Mar 2026 NCT07499414
active not recruiting Phase III Diabetes / Metabolic
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight is Active Not Recruiting •…
30 Mar 2026 NCT06388187
● Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat…
30 Mar 2026 NCT06872905
● Recruiting Phase III Dermatology
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] is Recruiting…
30 Mar 2026 NCT05895786
active not recruiting Phase III
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) is Active Not Recruiting •…
30 Mar 2026 NCT04770779
active not recruiting Phase II Oncology
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008)
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC)…
30 Mar 2026 NCT04895722
● Recruiting Phase I
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas is Recruiting • Phase…
30 Mar 2026 NCT05685173
● Recruiting Phase II
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene is Recruiting • Phase…
30 Mar 2026 NCT06627179
● Recruiting Gastroenterology
Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).
Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC). is Recruiting • Phase not applicable • Gastroenterology • NCT07192393.…
30 Mar 2026 NCT07192393